Haemophagocytic lymphohistiocytosis
RecruitingStudy of ELA026 for Treatment of Secondary Hemophagocytic Lymphohistiocytosis in Patients with Lymphoma Who Have Not Received Previous Treatment
Study of ELA026 for Treatment of Secondary Hemophagocytic Lymphohistiocytosis in Patients with Lymphoma Who Have Not Received Previous Treatment
- Disease:Haemophagocytic lymphohistiocytosis
- Substances:ELA026
Germany- Participants:0–17 years · 18–64 years · 65+ years
- Substances:ELA026
- Sponsor:Electra Therapeutics Inc.




